Inadequate Clearance of Translocated Bacterial Products in HIV-Infected Humanized Mice
Bacterial translocation from the gut and subsequent immune activation are hallmarks of HIV infection and are thought to determine disease progression. Intestinal barrier integrity is impaired early in acute retroviral infection, but levels of plasma lipopolysaccharide (LPS), a marker of bacterial translocation, increase only later. We examined humanized mice infected with HIV to determine if disruption of the intestinal barrier alone is responsible for elevated levels of LPS and if bacterial translocation increases immune activation. Treating uninfected mice with dextran sodium sulfate (DSS) induced bacterial translocation, but did not result in elevated plasma LPS levels. DSS-induced translocation provoked LPS elevation only when phagocytic cells were depleted with clodronate liposomes (clodrolip). Macrophages of DSS-treated, HIV-negative mice phagocytosed more LPS ex vivo than those of control mice. In HIV-infected mice, however, LPS phagocytosis was insufficient to clear the translocated LPS. These conditions allowed higher levels of plasma LPS and CD8+ cell activation, which were associated with lower CD4+/CD8+ cell ratios and higher viral loads. LPS levels reflect both intestinal barrier and LPS clearance. Macrophages are essential in controlling systemic bacterial translocation, and this function might be hindered in chronic HIV infection.
Vyšlo v časopise:
Inadequate Clearance of Translocated Bacterial Products in HIV-Infected Humanized Mice. PLoS Pathog 6(4): e32767. doi:10.1371/journal.ppat.1000867
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000867
Souhrn
Bacterial translocation from the gut and subsequent immune activation are hallmarks of HIV infection and are thought to determine disease progression. Intestinal barrier integrity is impaired early in acute retroviral infection, but levels of plasma lipopolysaccharide (LPS), a marker of bacterial translocation, increase only later. We examined humanized mice infected with HIV to determine if disruption of the intestinal barrier alone is responsible for elevated levels of LPS and if bacterial translocation increases immune activation. Treating uninfected mice with dextran sodium sulfate (DSS) induced bacterial translocation, but did not result in elevated plasma LPS levels. DSS-induced translocation provoked LPS elevation only when phagocytic cells were depleted with clodronate liposomes (clodrolip). Macrophages of DSS-treated, HIV-negative mice phagocytosed more LPS ex vivo than those of control mice. In HIV-infected mice, however, LPS phagocytosis was insufficient to clear the translocated LPS. These conditions allowed higher levels of plasma LPS and CD8+ cell activation, which were associated with lower CD4+/CD8+ cell ratios and higher viral loads. LPS levels reflect both intestinal barrier and LPS clearance. Macrophages are essential in controlling systemic bacterial translocation, and this function might be hindered in chronic HIV infection.
Zdroje
1. PandreaI
SodoraDL
SilvestriG
ApetreiC
2008 Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends in Immunology 29 419 428
2. DouekDC
RoedererM
KoupRA
2009 Emerging Concepts in the Immunopathogenesis of AIDS. Annual Review of Medicine 60
3. AncutaP
KamatA
KunstmanKJ
KimE-Y
AutissierP
2008 Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3 e2516 doi:10.1371/journal.pone.0002516
4. GregsonJN
SteelA
BowerM
GazzardBG
GotchFM
2009 Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals. AIDS 23 29 34
5. HuntPW
BrenchleyJ
SinclairE
McCuneJM
RolandM
2008 Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 197 126 133
6. MarchettiG
BellistriGM
BorghiE
TincatiC
FerramoscaS
2008 Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22 2035 2038
7. PapasavvasE
PistilliM
ReynoldsG
BuckiR
AzzoniL
2009 Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients. AIDS 23 369 375
8. BrenchleyJM
PriceDA
SchackerTW
AsherTE
SilvestriG
2006 Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12 1365 1371
9. HeiseC
MillerCJ
LacknerA
DandekarS
1994 Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis 169 1116 1120
10. VeazeyRS
DeMariaM
ChalifouxLV
ShvetzDE
PauleyDR
1998 Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 427 431
11. MehandruS
PolesMA
Tenner-RaczK
HorowitzA
HurleyA
2004 Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200 761 770
12. HoferU
SpeckRF
2009 Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin Immunopathol 31 257 266
13. PaiardiniM
FrankI
PandreaI
ApetreiC
SilvestriG
2008 Mucosal immune dysfunction in AIDS pathogenesis. AIDS Rev 10 36 46
14. GordonSN
KlattNR
BosingerSE
BrenchleyJM
MilushJM
2007 Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol 179 3026 3034
15. PandreaIV
GautamR
RibeiroRM
BrenchleyJM
ButlerIF
2007 Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol 179 3035 3046
16. BrenchleyJM
PaiardiniM
KnoxKS
AsherAI
CervasiB
2008 Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112 2826 2835
17. RaffatelluM
SantosRL
VerhoevenDE
GeorgeMD
WilsonRP
2008 Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14 421 428
18. TraggiaiE
ChichaL
MazzucchelliL
BronzL
PiffarettiJ-C
2004 Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice. Science 304 104 107
19. BaenzigerS
TussiwandR
SchlaepferE
MazzucchelliL
HeikenwalderM
2006 Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/−gamma c−/− mice. Proc Natl Acad Sci U S A 103 15951 15956
20. GorantlaS
SnellerH
WaltersL
SharpJG
PirruccelloSJ
2007 Human Immunodeficiency Virus Type 1 Pathobiology Studied in Humanized BALB/c-Rag2−/−{gamma}c−/− Mice. J Virol 81 2700 2712
21. BergesBK
WheatWH
PalmerBE
ConnickE
AkkinaR
2006 HIV-1 infection and CD4 T cell depletion in the humanized Rag2−/−gamma c−/− (RAG-hu) mouse model. Retrovirology 3 76
22. HoferU
BaenzigerS
HeikenwalderM
SchlaepferE
GehreN
2008 RAG2−/− gamma(c)−/− mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus. J Virol 82 12145 12153
23. WirtzS
NeufertC
WeigmannB
NeurathMF
2007 Chemically induced mouse models of intestinal inflammation. Nat Protocols 2 541
24. VetuschiA
LatellaG
SferraR
CaprilliR
GaudioE
2002 Increased Proliferation and Apoptosis of Colonic Epithelial Cells in Dextran Sulfate Sodium-Induced Colitis in Rats. Digestive Diseases and Sciences 47 1447 1457
25. TessnerTG
CohnSM
SchloemannS
StensonWF
1998 Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology 115 874 882
26. LiQ
EstesJD
DuanL
JessurunJ
PambuccianS
2008 Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis 197 420 429
27. HopfU
RamadoriG
MollerB
GalanosC
1984 Hepatocellular clearance function of bacterial lipopolysaccharides and free lipid A in mice with endotoxic shock. Am J Emerg Med 2 13 19
28. FreudenbergMA
FreudenbergN
GalanosC
1982 Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol 63 56 65
29. GitterA
BendfeldtK
SchulzkeJ
FrommM
2000 Leaks in the epithelial barrier caused by spontaneous and TNF-{alpha}-induced single-cell apoptosis. FASEB J 14 1749 1753
30. SmithAM
RahmanFZ
HayeeBH
GrahamSJ
MarksDJB
2009 Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 206 1883 1897
31. BiswasSK
Lopez-CollazoE
2009 Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends in Immunology 30 475 487
32. Adib-ConquyM
CavaillonJ-M
2002 Gamma Interferon and Granulocyte/Monocyte Colony-stimulating Factor Prevent Endotoxin Tolerance in Human Monocytes by Promoting Interleukin-1 Receptor-associated Kinase Expression and Its Association to MyD88 and Not by Modulating TLR4 Expression. Journal of Biological Chemistry 277 27927 27934
33. SchuchmannM
HermannF
HerkelJ
van der ZeeR
GallePR
2004 HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells. Immunology Letters 93 199 204
34. DalpkeAH
LehnerMD
HartungT
HeegK
2005 Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology 116 203 212
35. DolganiucA
NorkinaO
KodysK
CatalanoD
BakisG
2007 Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV Infection. Gastroenterology 133 1627 1636
36. LesterRT
YaoX-D
BallTB
McKinnonLR
OmangeWR
2009 HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers. PLoS ONE 4 e5644 doi:10.1371/journal.pone.0005644
37. MuthumaniK
HwangDS
ChooAY
MayilvahananS
DayesNS
2005 HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int Immunol 17 103 116
38. BiggsBA
HewishM
KentS
HayesK
CroweSM
1995 HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J Immunol 154 6132 6139
39. KedzierskaK
AzzamR
ElleryP
MakJ
JaworowskiA
2003 Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. Journal of Clinical Virology 26 247 263
40. KafKedzierska
JagMak
AaeJaworowski
AbgGreenway
AaViolo
2001 nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS 15 945 955
41. BaquiAA
MeillerTF
ZhangM
FalklerWAJr
1999 The effects of HIV viral load on the phagocytic activity of monocytes activated with lipopolysaccharide from oral microorganisms. Immunopharmacol Immunotoxicol 21 421 438
42. MarshallJD
ChehimiJ
GriG
KostmanJR
MontanerLJ
1999 The Interleukin-12-Mediated Pathway of Immune Events Is Dysfunctional in Human Immunodeficiency Virus-Infected Individuals. Blood 94 1003 1011
43. RockstrohJK
KreuzerKA
SauerbruchT
SpenglerU
1998 Protein levels of interleukin-12 p70 Holomer, its p40 chain and interferon-gamma during advancing HIV infection. Journal of Infection 37 282 286
44. ByrnesAA
HarrisDM
AtabaniSF
SabundayoBP
LanganSJ
2008 Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy. J Leukoc Biol 84 1447 1453
45. AyehunieS
SonnerborgA
Yemane-BerhanT
ZewdieDW
BrittonS
1993 Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia. Clin Exp Immunol 91 37 42
46. von SydowM
SonnerborgA
GainesH
StrannegardO
1991 Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 7 375 380
47. ShenR
RichterHE
ClementsRH
NovakL
HuffK
2009 Macrophages in Vaginal but Not Intestinal Mucosa Are Monocyte-Like and Permissive to Human Immunodeficiency Virus Type 1 Infection. J Virol 83 3258 3267
48. EmbretsonJ
ZupancicM
RibasJL
BurkeA
RaczP
1993 Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362 359 362
49. OrensteinJM
FoxC
WahlSM
1997 Macrophages as a Source of HIV During Opportunistic Infections. Science 276 1857 1861
50. BaenzigerS
HeikenwalderM
JohansenP
SchlaepferE
HoferU
2009 Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 113 377 388
51. MandlJN
BarryAP
VanderfordTH
KozyrN
ChavanR
2008 Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 14 1077 1087
52. HeilF
HemmiH
HochreinH
AmpenbergerF
KirschningC
2004 Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8. Science 303 1526 1529
53. LiuZ
CumberlandWG
HultinLE
PrinceHE
DetelsR
1997 Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 16 83 92
54. PerelsonAS
NeumannAU
MarkowitzM
LeonardJM
HoDD
1996 HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time. Science 271 1582 1586
55. WolthersKC
WismanGBA
OttoSA
de Roda HusmanA-M
SchaftN
1996 T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4+ T Cell Turnover. Science 274 1543 1547
56. CullenBR
GreeneWC
1989 Regulatory pathways governing HIV-1 replication. Cell 58 423 426
57. ZeisbergerSM
OdermattB
MartyC
Zehnder-FjallmanAH
Ballmer-HoferK
2006 Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95 272 281
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 4
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- The Effect of Vaccination on the Evolution and Population Dynamics of Avian Paramyxovirus-1
- Reconstitution of SARS-Coronavirus mRNA Cap Methylation
- Deficiencies in Jasmonate-Mediated Plant Defense Reveal Quantitative Variation in Pathogenesis
- A Timescale for Evolution, Population Expansion, and Spatial Spread of an Emerging Clone of Methicillin-Resistant